We are live on ! Find out more
VIR icon

Vir Biotechnology
VIR

175 hedge funds and large institutions have $3.24B invested in Vir Biotechnology in 2021 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 65 increasing their positions, 45 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more call options, than puts

Call options by funds: $27.1M | Put options by funds: $14.3M

44% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 45

42% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 26

6% more funds holding

Funds holding: 165 → 175 (+10)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

2.14% less ownership

Funds ownership: 59.16% → 57.02% (-2.1%)

11% less capital invested

Capital invested by funds: $3.64B → $3.24B (-$395M)

Holders
175
Holders Change
+10
Holders Change %
+6.06%
% of All Funds
3.06%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
37
Increased
65
Reduced
45
Closed
26
Calls
$27.1M
Puts
$14.3M
Net Calls
+$12.9M
Net Calls Change
+$4.15M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$41.5M
2
OIM
Oracle Investment Management
Connecticut
+$20.6M
3
APM
Avidity Partners Management
Texas
+$15.3M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$8.91M
5
BlackRock
BlackRock
New York
+$7.71M

Top Sellers

1
Capital International Investors
Capital International Investors
California
-$135M
2
GF
Gates Foundation
Washington
-$90.9M
3
PCM
Pathway Capital Management
California
-$22.3M
4
APF
Alaska Permanent Fund
Alaska
-$9.85M
5
Morgan Stanley
Morgan Stanley
New York
-$8.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
101
Profund Advisors
Maryland
$593K +$23.2K +537 +4%
Ameriprise
102
Ameriprise
Minnesota
$581K -$8.66K -200 -1%
Man Group
103
Man Group
United Kingdom
$575K +$226K +5,224 +65%
AIL
104
AGF Investments LLC
Ontario, Canada
$530K -$59.2K -1,367 -10%
CF
105
CNA Financial
Illinois
$522K +$2.17K +50 +0.4%
SEC
106
Seven Eight Capital
New York
$520K +$518K +11,957 New
PHS
107
Pekin Hardy Strauss
Illinois
$500K +$498K +11,500 New
Los Angeles Capital Management
108
Los Angeles Capital Management
California
$486K +$433 +10 +0.1%
Public Employees Retirement Association of Colorado
109
Public Employees Retirement Association of Colorado
Colorado
$481K – – –
CG
110
Cutler Group
California
$474K +$468K +10,800 +11,020%
CAC
111
Cowen and Company
New York
$472K +$470K +10,850 New
LCM
112
Laurion Capital Management
New York
$468K – – –
AB
113
Amalgamated Bank
New York
$465K -$28.5K -659 -6%
Teacher Retirement System of Texas
114
Teacher Retirement System of Texas
Texas
$448K +$85.6K +1,977 +24%
Victory Capital Management
115
Victory Capital Management
Texas
$443K +$59.6K +1,377 +16%
Handelsbanken Fonder
116
Handelsbanken Fonder
Sweden
$418K – – –
Nordea Investment Management
117
Nordea Investment Management
Sweden
$414K +$403K +9,303 New
Bank of Nova Scotia
118
Bank of Nova Scotia
Ontario, Canada
$413K -$51K -1,177 -11%
AQR Capital Management
119
AQR Capital Management
Connecticut
$413K +$411K +9,498 New
Wolverine Trading
120
Wolverine Trading
Illinois
$383K +$134K +3,094 +54%
VF
121
Virtu Financial
New York
$369K +$367K +8,479 New
AG
122
Algert Global
California
$356K +$354K +8,169 New
Osaic Holdings
123
Osaic Holdings
Arizona
$343K +$67.1K +1,549 +21%
Mitsubishi UFJ Asset Management
124
Mitsubishi UFJ Asset Management
Japan
$303K +$7.97K +184 +3%
GAM
125
Gotham Asset Management
New York
$301K +$300K +6,927 New
3 4
5
6 7

VIR Hedge Fund Activity: Q3 2021 in Review

175 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Vir Biotechnology (VIR) for Q3 2021, worth a combined $3.24B — down 11% from $3.64B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new VIR positions and 26 closed out — a net gain of 11 holders — while 65 added to existing stakes and 45 trimmed.

The largest buyer was Vanguard Group, adding an estimated $41.5M. The largest seller was Capital International Investors, cutting an estimated $135M.

  • 175 institutional investors held Vir Biotechnology (VIR) as of Q3 2021, up from 165 in Q2 2021.
  • Funds reported $3.24B of Vir Biotechnology stock for Q3 2021, down 11% quarter-over-quarter.
  • 37 funds opened new Vir Biotechnology positions in Q3 2021 and 26 closed out, a net change of +11 holders.
  • The largest Vir Biotechnology buyer in Q3 2021 was Vanguard Group, an estimated $41.5M added.
  • The largest Vir Biotechnology seller in Q3 2021 was Capital International Investors, an estimated $135M sold.

Based on aggregated 13F filings for Q3 2021.